COGT - CIK 0001622229
Cogent Biosciences, Inc. has filed 595 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (207 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Activist ownership stake (update) | SC 13D/A | 2024-06-13 | - |
| Activist ownership stake (update) | SC 13D/A | 2024-04-01 | - |
| Activist ownership stake (update) | SC 13D/A | 2024-03-27 | - |
| Activist ownership stake (update) | SC 13D/A | 2024-02-16 | - |
| Activist ownership stake (update) | SC 13D/A | 2023-06-13 | - |
| Activist ownership stake (update) | SC 13D/A | 2022-06-21 | - |